Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain – a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia.
The newest episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Tim Barry ‘93, the chair and CEO of VillageMD, and this year’s Cornell Entrepreneur of the Year. Entrepreneurship at Cornell will honor Barry on April 11 and 12 during the Celebration event on campus.
Science on Screen® supports creative pairings of current, classic, cult, and documentary films with introductions by figures from the world of science, technology and medicine.
Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural.
A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of follicular lymphoma, a type of blood cancer, from a slow-growing form to the aggressive form it takes in some patients.
Researchers have discovered a protein called SEL1L that plays a critical role in clearing collagen from tissue, and which may be a therapeutic target to help prevent fibrosis, scar tissue that interferes with organ function.
A new method can now find previously unknown factors that underlie disease by using statistical machine learning to sort through mountains of complex biological data.
While world public health agencies are focused on how to react to the next pandemic once it has started, a new plan proposes using ecological perspectives to prevent disease outbreaks before they happen.
By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide.
